Labiana Health S.A. (LAB) - Total Assets
Based on the latest financial reports, Labiana Health S.A. (LAB) holds total assets worth €57.54 Million EUR (≈ $67.27 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Labiana Health S.A. - Total Assets Trend (2021–2025)
This chart illustrates how Labiana Health S.A.'s total assets have evolved over time, based on quarterly financial data. Also see Labiana Health S.A. market capitalisation for the company's overall valuation and market capitalisation.
Labiana Health S.A. - Asset Composition Analysis
Current Asset Composition (December 2025)
Labiana Health S.A.'s total assets of €57.54 Million consist of 54.8% current assets and 45.2% non-current assets. Review Labiana Health S.A. (LAB) financial obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 10.3% |
| Accounts Receivable | €10.39 Million | 18.1% |
| Inventory | €12.03 Million | 20.9% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €6.19 Million | 10.8% |
| Goodwill | €-0.01 | 0.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how Labiana Health S.A.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Labiana Health S.A. stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Labiana Health S.A.'s current assets represent 54.8% of total assets in 2025, an increase from 43.0% in 2021.
- Cash Position: Cash and equivalents constituted 10.3% of total assets in 2025, up from 4.8% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, a decrease from 17.0% in 2021.
- Asset Diversification: The largest asset category is inventory at 20.9% of total assets.
Labiana Health S.A. Competitors by Total Assets
Key competitors of Labiana Health S.A. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Beijing Tongrentang Co Ltd
SHG:600085
|
China | CN¥31.82 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥30.77 Billion |
|
Neuland Laboratories Limited
NSE:NEULANDLAB
|
India | Rs29.30 Billion |
|
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062
|
China | CN¥17.01 Billion |
Labiana Health S.A. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.39 | 1.30 | 1.06 |
| Quick Ratio | 0.86 | 0.84 | 0.59 |
| Cash Ratio | 0.00 | 0.00 | 0.16 |
| Working Capital | €8.87 Million | €6.54 Million | €2.08 Million |
Labiana Health S.A. - Advanced Valuation Insights
This section examines the relationship between Labiana Health S.A.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 10.35 |
| Latest Market Cap to Assets Ratio | 0.94 |
| Asset Growth Rate (YoY) | 10.7% |
| Total Assets | €57.54 Million |
| Market Capitalization | $54.33 Million USD |
Valuation Analysis
Near Book Valuation: The market values Labiana Health S.A.'s assets close to their book value (0.94x), suggesting investors view the company's assets at approximately fair value.
Rapid Asset Growth: Labiana Health S.A.'s assets grew by 10.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Labiana Health S.A. (2021–2025)
The table below shows the annual total assets of Labiana Health S.A. from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €57.54 Million ≈ $67.27 Million |
+10.66% |
| 2024-12-31 | €52.00 Million ≈ $60.80 Million |
-12.05% |
| 2023-12-31 | €59.12 Million ≈ $69.12 Million |
-2.72% |
| 2022-12-31 | €60.78 Million ≈ $71.06 Million |
-11.10% |
| 2021-12-31 | €68.37 Million ≈ $79.93 Million |
-- |
About Labiana Health S.A.
Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, North America, and internationally. It offers anesthetics-sedatives, anti-infectives, anti-inflammatories, antiparasitics, hormonals, nutritional products, metabolism regulators, and vitamin products. The company also provides sterile and lyophilized dosage f… Read more